Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SEMAGLUTIDE for Obesity: Side Effects & Safety Data

Lose Weight Fast — The 21-Day Smoothie Diet

36 fat-burning recipes + shopping lists. Results in the first week.

Get the Program

There are 2,586 adverse event reports in the FDA FAERS database where SEMAGLUTIDE was used for Obesity.

Most Reported Side Effects for SEMAGLUTIDE

Side Effect Reports % Deaths Hosp.
Nausea 10,036 16.8% 67 2,069
Vomiting 6,518 10.9% 58 2,092
Off label use 5,425 9.1% 30 1,095
Diarrhoea 5,331 8.9% 42 1,392
Decreased appetite 4,317 7.2% 35 917
Constipation 4,036 6.8% 14 937
Weight decreased 3,518 5.9% 39 514
Impaired gastric emptying 2,622 4.4% 12 1,483
Product use in unapproved indication 2,613 4.4% 31 440
Wrong technique in product usage process 2,538 4.3% 4 150
Abdominal pain upper 2,503 4.2% 15 571
Headache 2,432 4.1% 12 259
Blood glucose increased 2,240 3.8% 15 284
Fatigue 2,196 3.7% 10 298
Inappropriate schedule of product administration 2,139 3.6% 14 396

Other Indications for SEMAGLUTIDE

Product used for unknown indication (24,996) Type 2 diabetes mellitus (17,910) Weight control (6,378) Diabetes mellitus (4,265) Weight decreased (1,680) Glucose tolerance impaired (1,475) Overweight (497) Type 1 diabetes mellitus (245) Glycosylated haemoglobin increased (229) Cardiovascular event prophylaxis (207)

Other Drugs Used for Obesity

LIRAGLUTIDE (1,090) BUPROPION\NALTREXONE (726) TIRZEPATIDE (700) ORLISTAT (163) PHENTERMINE (127) DULAGLUTIDE (109) METFORMIN (100) PHENTERMINE\TOPIRAMATE (86) TOPIRAMATE (86) LORCASERIN (79)

Related Pages

SEMAGLUTIDE Full Profile All Obesity Drugs SEMAGLUTIDE Demographics SEMAGLUTIDE Timeline